AU4035893A - 3-substituted imidazo (1,5-a) and imidazo (1,5-a)-triazolo (1,5-c) quinoxalines and quinazolines with cns activity - Google Patents
3-substituted imidazo (1,5-a) and imidazo (1,5-a)-triazolo (1,5-c) quinoxalines and quinazolines with cns activityInfo
- Publication number
- AU4035893A AU4035893A AU40358/93A AU4035893A AU4035893A AU 4035893 A AU4035893 A AU 4035893A AU 40358/93 A AU40358/93 A AU 40358/93A AU 4035893 A AU4035893 A AU 4035893A AU 4035893 A AU4035893 A AU 4035893A
- Authority
- AU
- Australia
- Prior art keywords
- imidazo
- quinoxalines
- quinazolines
- triazolo
- cns activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80956491A | 1991-12-17 | 1991-12-17 | |
US809564 | 1991-12-17 | ||
US84006392A | 1992-02-21 | 1992-02-21 | |
US840063 | 1992-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4035893A true AU4035893A (en) | 1993-07-19 |
Family
ID=27123233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU40358/93A Abandoned AU4035893A (en) | 1991-12-17 | 1992-12-07 | 3-substituted imidazo (1,5-a) and imidazo (1,5-a)-triazolo (1,5-c) quinoxalines and quinazolines with cns activity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4035893A (en) |
WO (1) | WO1993012113A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8263630B2 (en) | 2008-02-12 | 2012-09-11 | Bristol-Myers Squibb Company | 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors |
CN102341399A (en) | 2009-03-05 | 2012-02-01 | 安斯泰来制药株式会社 | Quinoxaline compounds |
CA2810659A1 (en) | 2010-09-07 | 2012-03-15 | Astellas Pharma Inc. | Quinoxaline compound |
PE20140236A1 (en) * | 2011-02-23 | 2014-03-14 | Pfizer | IMIDAZO [5,1-f] [1,2,4] TRIAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
WO2017149469A1 (en) * | 2016-03-03 | 2017-09-08 | Emcure Pharmaceuticals Limited | Heterocyclic compounds useful as ido and/or tdo modulators |
WO2020139988A1 (en) * | 2018-12-28 | 2020-07-02 | Forma Therapeutics, Inc. | Compositions for inhibiting ubiquitin specific protease 1 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440929A (en) * | 1981-07-16 | 1984-04-03 | Usv Pharmaceutical Corporation | Imidazoquinoxaline compounds |
DK476885D0 (en) * | 1985-10-17 | 1985-10-17 | Ferrosan As | HETEROCYCLIC RELATIONS AND PROCEDURES FOR PREPARING IT |
DE3686723T2 (en) * | 1985-10-17 | 1993-04-01 | Novo Nordisk As | OXADIAZOLYL ACETONITRILE, THEIR PRODUCTION AND USE. |
DK155524C (en) * | 1987-03-18 | 1989-09-11 | Ferrosan As | CONDENSED IMIDAZOLD DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE |
DK626288D0 (en) * | 1988-11-10 | 1988-11-10 | Ferrosan As | CHEMICAL PROCESS FOR THE PREPARATION OF IMIDAZOQUINOXALINES AND INTERMEDIATES FOR USE IN THE PROCESS |
DK41191D0 (en) * | 1991-03-07 | 1991-03-07 | Novo Nordisk As | HETEROCYCLIC RELATIONSHIPS, THEIR PREPARATION AND USE |
-
1992
- 1992-12-07 AU AU40358/93A patent/AU4035893A/en not_active Abandoned
- 1992-12-07 WO PCT/US1992/010388 patent/WO1993012113A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1993012113A1 (en) | 1993-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU556062B2 (en) | Imidazo (1,2-a) pyridines and pyrazines | |
GB2196627B (en) | Intermediate 1,2,4-triazolo 1,5-a pyrimidine-2-sulfonyl chloridess | |
ZA931945B (en) | Optionally substituted pyrido(2,3-d)pyrimidine-2,4(1H,3H)-diones and pyrido(2,3-d) pyrimidine-2(1H,3H)-ones | |
PH25298A (en) | 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo (1,5-a) pyrimidines | |
AU4707689A (en) | Phenylsulfamoyl-1,2,4-triazolo(1,5-a)pyrimidines | |
AU3443493A (en) | 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity | |
EP0584487A3 (en) | 4,5-dihydro-4-oxopyrrolo (1,2-a) quinoxalines and aza-analoges and process for their preparation | |
AU7980087A (en) | 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo-{1,5-a}pyrimidines | |
AU4035893A (en) | 3-substituted imidazo (1,5-a) and imidazo (1,5-a)-triazolo (1,5-c) quinoxalines and quinazolines with cns activity | |
EP0541404A3 (en) | Pyrimido(4,5-g)quinazoline derivatives with anti-tumour activity | |
NZ320537A (en) | 2,7-substituted octahydro-pyrrolo(1,2-a)pyrazine derivatives | |
NZ229346A (en) | Oxadiazolyl-substituted imidazo(1,5-a)quinoxaline derivatives and pharmaceutical compositions | |
AU8840282A (en) | 1,2,4-triazolo (1,5-a( quinoxalines and pyrido(2,3-e) (1,2,4)-triazolo (1,5-a)pyrazines | |
AU4421485A (en) | Imidazo pyrazine and imidazo pyrimidine derivatives | |
AU587496B2 (en) | Substituted dihydroimidazo (1,2-a) quinoxalines | |
AU573880B2 (en) | Imidazo (1.2-a) quinolines | |
AU552065B2 (en) | Pyrrolo and pyrido (2,1-b) quinazolines | |
AU3237984A (en) | Imidazo (1,5-a) (1,4) benzodiazepines | |
AU565545B2 (en) | Triazolo(4,3-c) and (1,5-c)pyrimidines | |
ZA957464B (en) | Pyrimido[5,4-d]pyrimidines medicaments comprising these compounds their use and processes for the preparation | |
AU7105894A (en) | 1,2,3,4-tetrahydropyrrolo{1,2-a}pyrazines | |
GB2205565B (en) | Imidazo-[1,2-a]-pyrimidin-2-oyl and imidazo-[1,2-a]quinazolin-2-oyl cyclopropane derivatives | |
ZA873934B (en) | 2,3-dihydro-1-(8-methyl-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4(1h)-pyridinone | |
GB8309261D0 (en) | Pyrrolo(2,1-b)quinazolines and pyrido(2,1-b)quinazoline | |
GB8530144D0 (en) | Imidazo(1,5-a)heterocyclic compounds |